Somatostatin receptor 3

SSTR3
Identifiers
AliasesSSTR3, SS-3-R, SS3-R, SS3R, SSR-28, Somatostatin receptor 3
External IDsOMIM: 182453; MGI: 98329; GeneCards: SSTR3
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

6753

20607

Ensembl

ENSG00000278195

ENSMUSG00000044933

UniProt

P32745

P30935

RefSeq (mRNA)

NM_001051
NM_001278687

NM_009218
NM_001356961

RefSeq (protein)

NP_001042
NP_001265616

NP_033244
NP_001343890

Location (UCSC)Chr 22: 37.2 – 37.21 MbChr 15: 78.42 – 78.43 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Somatostatin receptor type 3 is a protein that in humans is encoded by the SSTR3 gene.[5][6]

Function

Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biological effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR3 is a member of the superfamily of receptors having seven transmembrane segments and is expressed in highest levels in brain and pancreatic islets. SSTR3 is functionally coupled to adenylyl cyclase.[6]

Ligands

Agonists
Antagonists

See also

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000278195 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000044933 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Yamada Y, Stoffel M, Espinosa R, Xiang KS, Seino M, Seino S, et al. (February 1993). "Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms". Genomics. 15 (2): 449–452. doi:10.1006/geno.1993.1088. PMID 8449518.
  6. 1 2 "Entrez Gene: SSTR3 somatostatin receptor 3".
  7. ↑ Florio T, Morini M, Villa V, Arena S, Corsaro A, Thellung S, et al. (April 2003). "Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities". Endocrinology. 144 (4): 1574–1584. doi:10.1210/en.2002-220949. PMID 12639942.
  8. ↑ Poitout L, Roubert P, Contour-Galcéra MO, Moinet C, Lannoy J, Pommier J, et al. (30 August 2001). "Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity". Journal of Medicinal Chemistry. 44 (18): 2990–3000. doi:10.1021/jm0108449. PMID 11520208.
  9. ↑ Shah SK, He S, Guo L, Truong Q, Qi H, Du W, et al. (18 March 2015). "Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes". ACS Medicinal Chemistry Letters. 6 (5): 513–517. doi:10.1021/ml500514w. PMC 4434471. PMID 26005524.
  10. ↑ He S, Ye Z, Truong Q, Shah S, Du W, Guo L, et al. (7 May 2012). "The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes". ACS Medicinal Chemistry Letters. 3 (6): 484–489. doi:10.1021/ml300063m. PMC 4025728. PMID 24900499.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.